Lunai Bioworks Announces Delisting from Nasdaq
Lunai Bioworks received a determination that it no longer complies with a Nasdaq listing rule due to a shareholder deficit. The company intends to voluntarily delist its shares, suspending trading and its SEC reporting obligations.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed